Pembrolizumab (Anti-PD-1) and AMG386 (Angiopoietin-2 (Ang-2) in Patients With Advanced Solid Tumor
Dana-Farber Cancer Institute
Dana-Farber Cancer Institute
The Methodist Hospital Research Institute
Psyence Australia Pty Ltd
Dana-Farber Cancer Institute
Pfizer
Tizona Therapeutics, Inc
Essen Biotech
A2 Biotherapeutics Inc.
University of Nebraska
Adela, Inc
Second Life Therapeutics
Elephas
Novartis
Elephas
University of Pittsburgh
Medtronic - MITG
UNC Lineberger Comprehensive Cancer Center
Washington University School of Medicine
Institut Claudius Regaud
A2 Biotherapeutics Inc.
Institut Bergonié
ModeX Therapeutics, An OPKO Health Company
University of Alabama at Birmingham
Cancer Research UK
Tempus AI
Arbeitsgemeinschaft medikamentoese Tumortherapie
Memorial Sloan Kettering Cancer Center
Elevation Oncology
Pfizer
Molecure S.A.
University Health Network, Toronto
Universidade Federal de Pernambuco
Aurigene Discovery Technologies Limited
Astellas Pharma Inc
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
DxTerity Diagnostics
Cedars-Sinai Medical Center
Sumitomo Pharma America, Inc.
Celldex Therapeutics
Corvus Pharmaceuticals, Inc.
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
Barbara Ann Karmanos Cancer Institute
Canadian Cancer Trials Group
Kineta Inc.
Eastern Cooperative Oncology Group
Janssen Research & Development, LLC
Quadriga Biosciences, Inc.
Exact Sciences Corporation
Imperial College London
Roswell Park Cancer Institute